Clinica Doctor Balcangiu-Stroescu

Nutritional Monitoring in Pregnancy and Gestational Diabetes

Nutritional Monitoring in Pregnancy and Gestational Diabetes
Useful information
February 28, 2026Andra-Elena Balcangiu-Stroescu

Pregnancy is a period of complex metabolic adaptation, and in the context of gestational diabetes, glycemic balance becomes a priority therapeutic objective.

Why is metabolic control essential during pregnancy?

Glycemic imbalances can influence:

· excessive fetal growth (macrosomia)

· risk of premature delivery

· obstetric complications

· subsequent metabolic predisposition of the child

Correct nutritional intervention significantly reduces these risks and optimizes pregnancy progression.

What are the correct steps for proper nutritional monitoring during pregnancy and gestational diabetes

1. Complex initial assessment

· analysis of preconception body mass index

· establishment of individual caloric requirements

· evaluation of glycemic profile

· identification of possible nutritional deficiencies

2. Personalized nutritional plan

The dietary plan is adapted to:

· trimester of pregnancy

· increased protein requirements

· controlled distribution of carbohydrates

· requirement of essential fatty acids (DHA)

· particularities of gestational diabetes

Safe foods are prioritized, adequately prepared thermally, with controlled glycemic index and adequate fiber intake.

3. Continuous monitoring

Monitoring includes:

· tracking weight gain

· adjustment of caloric intake based on progression

· monitoring of blood glucose levels

· recommendations adapted to treatment (dietary or insulin)

Intervention is dynamic, not static.

Micronutrient component

Special attention is given to supplementation and monitoring of:

· folic acid

· iron

· vitamin D

· calcium

· choline

· vitamin B12 (where applicable)

Supplementation is individualized, avoiding unnecessary or potentially harmful excess (such as vitamin A in large doses).

Food safety

Education regarding:

· avoidance of raw or insufficiently prepared foods

· selection of fish with low mercury content

· exclusive use of pasteurized dairy products

· adequate hydration

· complete elimination of alcohol and tobacco

What are the categories of patients requiring metabolic monitoring during pregnancy

· Pregnant women with gestational diabetes

· Women with type 1 or type 2 diabetes mellitus who are planning or have achieved pregnancy

· Women with increased metabolic risk

· Overweight or obese patients who are pregnant

Clinical vision

The main objective is not only glycemic control, but long-term metabolic protection of both mother and child.

Nutrition, when medically structured and carefully monitored, becomes an essential therapeutic tool in preventing obstetric and metabolic complications.

Excellence in maternal medicine means active prevention, precision, and personalization.

Also Read

Related Articles

A single injection for cholesterol — from dreams to first human results
Useful information

A single injection for cholesterol — from dreams to first human results

A Phase 1 trial published in the New England Journal of Medicine (November 2025) brings remarkable results: a single infusion of CTX310, a CRISPR-Cas9 therapy developed by Cleveland Clinic and CRISPR Therapeutics, reduced LDL cholesterol by up to 49% and triglycerides by up to 55% in patients with refractory dyslipidemia — without serious adverse events. The mechanism is unique: instead of blocking a protein or interfering with its mRNA, CTX310 permanently edits the ANGPTL3 gene in hepatic cells, mimicking a natural mutation associated with reduced cardiovascular risk throughout life. The therapy is currently in Phase 1b clinical stage, with updates expected in the second half of 2026. It is not approved and does not replace current treatments. Read the full article for clinical context, comparison with statins and PCSK9 inhibitors, and what these data mean for patients. Medical Disclaimer This article presents results from a Phase 1 clinical trial in an early-stage research phase. The therapy described is not approved and is not available as standard treatment. The information is for educational purposes only. Consult your physician for any medical decision.

June 1, 2026Andra-Elena Balcangiu-Stroescu

Ready to schedule?

Book an appointment online or call us directly.

+40 747 777 107